Antidepressant use in the European union: Perceived indications and patterns

Psychiatric Services

Volumn 64, Issue 3, 2013, Pages 208-

  Samples, Hillary ^a   Mojtabai, Ramin ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ADOLESCENT; ANXIETY DISORDER; CHRONIC PAIN; DEPRESSION; DRUG EFFICACY; DRUG INDICATION; DRUG USE; EUROPEAN UNION; HEALTH CARE SURVEY; HUMAN; MAJOR CLINICAL STUDY; MEDICATION COMPLIANCE; NOTE; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSION; EUROPEAN UNION; HEALTH CARE SURVEYS; HUMANS; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; YOUNG ADULT;

EID: 84883070326     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/appi.ps.005622012     Document Type: Note

References (2)

1. Olfson M, Marcus SC, Tedeschi M, et al: Continuity of antidepressant treatment for adults with depression in the United States. American Journal of Psychiatry 163: 101-108, 2006
2. European Commission: Mental Health: Part 1 Report. Brussels, Belgium, European Commission, 2010. Available at ec.europa.eu/health/mental-health/docs/ ebs-345-en.pdf